Active Portfolio
» USA - Private
» Europe - Private
» Public Companies
Portfolio Since Inception
2008
April 30
CoNCERT Pharmaceuticals Raises $37M in Series C Financing
2007
October 31
Syntaxin Raises £16 Million in Series B Fundraising
October 16
Metastatix Appoints President and CEO
October 9
Metastatix Closes $35 Million Series B Financing
September 7
Ablynx and Boehringer Ingelheim Announce Major Global Strategic Alliance
July 12
Brad Wilson joins PharmaKodex as Chairman of the Board
July 2
Ablynx Announces Interim Results of First Phase I Nanobody Study
June 29
New Ticker Symbol for Redpoint Bio
June 7
7TM Pharma raises DKK123 million in financing round
April 17
Eisai Announces Completion of Acquisition of Morphotek
April 3
TA Associates Completes $175 Million Buyout of Alere Medical
April 3
Lilly Announces Completion of Hypnion Acquisition
March 26
Algeta raises NOK 250 million in successful offering
March 12
Redpoint Bio and Robcor Properties Complete Reverse Merger
February 13
Locus Pharmaceuticals Completes $30.2 Million Financing Round
February 8
Joyce A. Lonergan to Head SR One
2006
November 16
PharmaKodex Raises 7.1 million ($13.5 million)
September 26
Resistentia raises EUR 11 million
September 19
Addex Pharmaceuticals Raises CHF40 million
September 7
Metastatix Completes Series A Financing
August 23
Ablynx Completes 40 Million (~US$50 Million) Series
August 7
Cabrellis Pharmaceuticals Corporation Raises $27.5 Million
2005
September 2
Algeta ASA Raises Euro 23 Million
August 30
Protez Pharmaceuticals Closes $15 Million Financing
May 19
Zelos Therapeutics Raises $42.5 Million Financing
March 14
SR One leads Series C Financing of Novalar Pharmaceuticals
January 24
SR One Co-Leads Euro 18 million investment in Octoplus